mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Feldman, Robert A., Fuhr, Rainard, Smolenov, Igor, (Mick) Ribeiro, Amilcar, Panther, Lori, Watson, Mike, Senn, Joseph J., Smith, Mike, Almarsson, Ӧrn, Pujar, Hari S., Laska, Michael E., Thompson, James, Zaks, Tal, Ciaramella, Giuseppe
Published in Vaccine (31.05.2019)
Published in Vaccine (31.05.2019)
Get full text
Journal Article
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Bahl, Kapil, Senn, Joe J., Yuzhakov, Olga, Bulychev, Alex, Brito, Luis A., Hassett, Kimberly J., Laska, Michael E., Smith, Mike, Almarsson, Örn, Thompson, James, Ribeiro, Amilcar (Mick), Watson, Mike, Zaks, Tal, Ciaramella, Giuseppe
Published in Molecular therapy (07.06.2017)
Published in Molecular therapy (07.06.2017)
Get full text
Journal Article
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Bahl, Kapil, Senn, Joe J., Yuzhakov, Olga, Bulychev, Alex, Brito, Luis A., Hassett, Kimberly J., Laska, Michael E., Smith, Mike, Almarsson, Örn, Thompson, James, Ribeiro, Amilcar (Mick), Watson, Mike, Zaks, Tal, Ciaramella, Giuseppe
Published in Molecular therapy (03.08.2022)
Published in Molecular therapy (03.08.2022)
Get full text
Journal Article